Filing metadata

Accession number
0001209191-22-058133
Form type
Form 4
Filer
KalVista Pharmaceuticals, Inc.
CIK
CIK 1348911
Filed
Nov 21, 2022
Reporting period
Nov 17, 2022
Description
Insider transaction

Explore SEC Filings Hub